These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16697865)

  • 1. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.
    Moussa O; Abol-Enein H; Bissada NK; Keane T; Ghoneim MA; Watson DK
    J Urol; 2006 Jun; 175(6):2312-6. PubMed ID: 16697865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.
    Eissa S; Swellam M; Shehata H; El-Khouly IM; El-Zayat T; El-Ahmady O
    J Urol; 2010 Feb; 183(2):493-8. PubMed ID: 20006858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
    Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
    Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
    Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
    Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
    Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
    Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of survivin mRNA expression in bladder transitional cell carcinomas.
    Kitsukawa S; Aoyagi T; Noda K; Ito T; Yamamoto Y; Hosoda S; Otsuru N; Matsumoto T
    Hinyokika Kiyo; 2008 Feb; 54(2):101-6. PubMed ID: 18323166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary application study in early diagnosis of bladder cancer by survivin molecular beacons.
    Zhao J; He D; He H; Li L; Zhang LL; Wang XY
    Urology; 2007 Jul; 70(1):60-4. PubMed ID: 17656209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis.
    Kishi H; Igawa M; Kikuno N; Yoshino T; Urakami S; Shiina H
    J Urol; 2004 May; 171(5):1855-60. PubMed ID: 15076293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.
    Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Rucker EB; Knapp DW; Rodriguez CO; Green JA
    Vet Comp Oncol; 2008 Sep; 6(3):141-50. PubMed ID: 19178674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
    Warnecke-Eberz U; Hokita S; Xi H; Higashi H; Baldus SE; Metzger R; Brabender J; Bollschweiler E; Mueller RP; Dienes HP; Hoelscher AH; Schneider PM
    Oncol Rep; 2005 Jun; 13(6):1241-6. PubMed ID: 15870949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin mRNA expression in urine as a biomarker for patients with transitional cell carcinoma of bladder.
    Hou JQ; He J; Wen DG; Chen ZX; Zeng J
    Chin Med J (Engl); 2006 Jul; 119(13):1118-20. PubMed ID: 16834932
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.
    Tanabe H; Yagihashi A; Tsuji N; Shijubo Y; Abe S; Watanabe N
    Lung Cancer; 2004 Dec; 46(3):299-304. PubMed ID: 15541814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of newly diagnosed bladder cancer, bladder cancer recurrence and bladder cancer in patients with hematuria using quantitative rt-PCR of urinary survivin.
    Kenney DM; Geschwindt RD; Kary MR; Linic JM; Sardesai NY; Li ZQ
    Tumour Biol; 2007; 28(2):57-62. PubMed ID: 17259754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer.
    Eissa S; Zohny SF; Swellam M; Mahmoud MH; El-Zayat TM; Salem AM
    Clin Biochem; 2008 Nov; 41(16-17):1335-41. PubMed ID: 18804101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of survivin mRNA in peritoneal lavage fluid from patients with gastric carcinoma.
    Wang ZN; Xu HM; Jiang L; Zhou X; Lu C; Zhang X
    Chin Med J (Engl); 2004 Aug; 117(8):1210-7. PubMed ID: 15361297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
    Shen C; Hu L; Xia L; Li Y
    Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.